human-4-1bb-monoclonal-antibody Videos
3 videos found
Feb. 13, 2023
SNNLive caught up with Matthew Jones, Managing Director of Business Development and Licensing of Dyadic International, Inc. (OTCQX: DYAI) at the Dawson James Small Cap Growth Conference 2016 in Jupiter, FL. For more information about Dyadic International, Inc., please visit: http://www.dyadic.com/ The interview may contain forward looking statements about Dyadic International, Inc. See Dyadic ...
Feb. 12, 2018
Tonix Pharmaceuticals Holding Corp. CEO Seth Lederman talks to Proactive about the New Jersey-based clinical-stage biopharmaceutical company's 2021 highlights. Lederman says the group ended the year with $179 million in cash and cash equivalents, entering 2022 'poised for growth.' Lederman highlights the FDA's recent award of Orphan-Drug designation for Tonix's TNX-2900 to treat Prader Willi ...
Nov. 30, 2022